N. Barnes

839 total citations
15 papers, 533 citations indexed

About

N. Barnes is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, N. Barnes has authored 15 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 11 papers in Pulmonary and Respiratory Medicine and 2 papers in Immunology and Allergy. Recurrent topics in N. Barnes's work include Asthma and respiratory diseases (13 papers), Respiratory and Cough-Related Research (9 papers) and Inhalation and Respiratory Drug Delivery (5 papers). N. Barnes is often cited by papers focused on Asthma and respiratory diseases (13 papers), Respiratory and Cough-Related Research (9 papers) and Inhalation and Respiratory Drug Delivery (5 papers). N. Barnes collaborates with scholars based in United Kingdom. N. Barnes's co-authors include K.P. Hui, Mark A. Payton, Toby C. Lewis, L. Pearce Collins, Roy Pettipher, Debbie Parker, John I. Bell, Christopher Perkins, А. Г. Чучалин and J. A. Steiner and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and European Respiratory Journal.

In The Last Decade

N. Barnes

15 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Barnes United Kingdom 8 425 293 106 87 66 15 533
So-Hee Lee South Korea 14 179 0.4× 137 0.5× 70 0.7× 54 0.6× 46 0.7× 33 407
Tatyana Gavrilova United States 6 150 0.4× 66 0.2× 45 0.4× 80 0.9× 28 0.4× 13 302
Véronique Provost Canada 7 158 0.4× 60 0.2× 47 0.4× 116 1.3× 51 0.8× 8 320
B Melander Sweden 11 569 1.3× 572 2.0× 65 0.6× 23 0.3× 18 0.3× 13 724
Rafael Bonamichi-Santos Brazil 6 142 0.3× 62 0.2× 56 0.5× 75 0.9× 41 0.6× 7 296
Marie-Chantal Larose Canada 6 147 0.3× 57 0.2× 42 0.4× 114 1.3× 48 0.7× 7 303
César Villarán United States 9 410 1.0× 356 1.2× 95 0.9× 21 0.2× 28 0.4× 11 462
Sümeyye Alparslan Bekir Türkiye 5 248 0.6× 223 0.8× 54 0.5× 29 0.3× 15 0.2× 14 352
Xiaohong Yue China 9 263 0.6× 137 0.5× 527 5.0× 34 0.4× 156 2.4× 21 755
Samantha Souza Possa Brazil 6 181 0.4× 127 0.4× 26 0.2× 77 0.9× 50 0.8× 8 311

Countries citing papers authored by N. Barnes

Since Specialization
Citations

This map shows the geographic impact of N. Barnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Barnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Barnes more than expected).

Fields of papers citing papers by N. Barnes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Barnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Barnes. The network helps show where N. Barnes may publish in the future.

Co-authorship network of co-authors of N. Barnes

This figure shows the co-authorship network connecting the top 25 collaborators of N. Barnes. A scholar is included among the top collaborators of N. Barnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Barnes. N. Barnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Barnes, N., Ian Pavord, А. Г. Чучалин, et al.. (2011). A randomized, double‐blind, placebo‐controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma. Clinical & Experimental Allergy. 42(1). 38–48. 175 indexed citations
3.
Hallsworth, Michael, P J Major, & N. Barnes. (2004). Where next in clinical asthma research? An innovative approach to research prioritisation. Thorax. 59. 32–33. 1 indexed citations
4.
Ram, Felix SF, et al.. (2003). Inspiratory muscle training for asthma. Physiotherapy. 89(12). 694–694. 1 indexed citations
5.
Barnes, N.. (2001). Outcome measures in asthma. 1(3). 261–263. 5 indexed citations
6.
Barnes, N.. (2000). Effects of Antileukotrienes in the Treatment of Asthma. American Journal of Respiratory and Critical Care Medicine. 161(Supplement_1). S73–S76. 36 indexed citations
7.
Barnes, N.. (2000). Outcome measures in asthma. Thorax. 55(90001). 70S–74. 8 indexed citations
8.
9.
Barnes, N.. (1997). Are leukotrienes involved in causing bronchial hyperresponsiveness?. European Respiratory Journal. 10(12). 2701–2703. 4 indexed citations
10.
Kon, Onn Min & N. Barnes. (1997). Immunosuppressive treatment in asthma.. PubMed. 57(8). 383–6. 2 indexed citations
11.
Barnes, N.. (1994). Role of inhaled corticosteroids in the treatment of asthma. Respiratory Medicine. 88. 1–4. 4 indexed citations
12.
Jarad, N.A., et al.. (1994). Effects of a thromboxane receptor antagonist on prostaglandin D2 and histamine induced bronchoconstriction in man.. British Journal of Clinical Pharmacology. 37(1). 97–100. 13 indexed citations
13.
Barnes, N.. (1993). New developments in the treatment of asthma and chronic obstructive pulmonary disease. Respiratory Medicine. 87. 53–56. 8 indexed citations
14.
Taylor, Rebecca F., et al.. (1992). Betel-nut chewing and asthma. The Lancet. 339(8802). 1134–1136. 68 indexed citations
15.
Hui, K.P. & N. Barnes. (1991). Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist. The Lancet. 337(8749). 1062–1063. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by So-Hee Lee Breakdown of academic impact, for papers by Tatyana Gavrilova Breakdown of academic impact, for papers by Véronique Provost Breakdown of academic impact, for papers by B Melander Breakdown of academic impact, for papers by Rafael Bonamichi-Santos Breakdown of academic impact, for papers by Marie-Chantal Larose Breakdown of academic impact, for papers by César Villarán Breakdown of academic impact, for papers by Sümeyye Alparslan Bekir Breakdown of academic impact, for papers by Xiaohong Yue Breakdown of academic impact, for papers by Samantha Souza Possa
Rankless by CCL
2026